The primitive ontology strategy to quantum mechanics seeks to account for quantum phenomena by way of a distribution of matter in three-dimensional area (or four-dimensional spacetime) and a regulation of nature that describes its temporal growth. This strategy to explaining quantum phenomena is appropriate with both a Humean or powerist account of legal guidelines.
On this paper, I provide a powerist ontology during which the regulation is specified by Bohmian mechanics for a worldwide configuration of particles. Not like in different powerist ontologies, nevertheless, this regulation isn’t grounded in a structural energy that’s instantiated by the worldwide configuration. As an alternative, I mix the primitive ontology strategy with Aristotle’s doctrine of hylomorphism to create a brand new metaphysical mannequin, during which the cosmos is a hylomorphic substance with an intrinsic energy to choreograph the trajectories of the particles.
Use of a modular ontology and a semantic annotation device to explain the care pathway of sufferers with amyotrophic lateral sclerosis in a coordination community
The target of this examine was to explain the care pathway of sufferers with amyotrophic lateral sclerosis (ALS) primarily based on real-life textual knowledge from a regional coordination community, the Ile-de-France ALS community. This coordination community gives look after 92% of sufferers recognized with ALS residing in Ile-de-France. We developed a modular ontology (OntoPaRON) for the automated processing of those unstructured textual knowledge. OntoPaRON has completely different modules: the core, medical, socio-environmental, coordination, and consolidation modules.
Our strategy was distinctive in its creation of totally outlined ideas at completely different ranges of the modular ontology to handle particular matters regarding healthcare trajectories. We additionally created a semantic annotation device particular to the French language and the specificities of our corpus, the Ontology-Primarily based Semantic Annotation Module (OnBaSAM), utilizing the OntoPaRON ontology as a reference. We used these instruments to annotate the data of 928 sufferers robotically. The semantic (qualitative) annotations of the ideas have been remodeled into quantitative knowledge.
By utilizing these pipelines we have been in a position to remodel unstructured textual knowledge into structured quantitative knowledge. Primarily based on knowledge processing, semantic annotations, sociodemographic knowledge for the affected person and medical variables, we discovered that the necessity and demand for human and technical help rely on the preliminary type of the illness, the motor state, and the affected person age. The presence of exhaustion in care administration, is said to the affected person’s motor and cognitive state.

The Finish of a Classical Ontology for Quantum Mechanics?
On this paper, I argue that the Shrapnel-Costa no-go theorem undermines the final remaining viability of the view that the basic ontology of quantum mechanics is basically classical: that’s, the view that bodily actuality is underpinned by objectively actual, counterfactually particular, uniquely spatiotemporally outlined, native, dynamical entities with determinate valued properties, and the place usually ‘quantum’ behaviour emerges as a operate of our personal in-principle ignorance of such entities.
Name this view Einstein-Bell realism. One can present that the causally symmetric native hidden variable strategy to deciphering quantum concept is essentially the most pure interpretation that follows from Einstein-Bell realism, the place causal symmetry performs a big function in circumventing the nonclassical penalties of the standard no-go theorems. Nevertheless, Shrapnel and Costa argue that unique causal constructions, similar to causal symmetry, are incapable of explaining quantum behaviour as arising on account of noncontextual ontological properties of the world. That is significantly worrying for Einstein-Bell realism and classical ontology.
Within the first occasion, the apparent consequence of the theory is an easy rejection of Einstein-Bell realism. Nevertheless, greater than this, I argue that, even the place there appears to be a chance of accounting for contextual ontic variables inside a causally symmetric framework, the price of such an account undermines a key benefit of causal symmetry: that accepting causal symmetry is extra economical than rejecting a classical ontology. Both approach, it appears like we should always surrender on classical ontology.
Recombinant Humanp21 Recombinant Protein |
ProSci |
Recombinant phosphopantetheine adenylyltransferase (PPAT) (Recombinant) |
Abbexa |
Glyco Recombinant Protein A33 Recombinant Protein |
ProSci |
Glyco Recombinant Protein A33 Recombinant Protein |
ProSci |
STAG3L1 Recombinant Protein (Human) (Recombinant Tag) |
ABM |
CellO: complete and hierarchical cell kind classification of human cells with the Cell Ontology
Cell kind annotation is a elementary activity within the evaluation of single-cell RNA-sequencing knowledge. On this work, we current CellO, a machine learning-based device for annotating human RNA-seq knowledge with the Cell Ontology. CellO allows correct and standardized cell kind classification of cell clusters by contemplating the wealthy hierarchical construction of identified cell varieties. Moreover, CellO comes pre-trained on a complete knowledge set of human, wholesome, untreated main samples within the Sequence Learn Archive.
CellO’s complete coaching set allows it to expire of the field on various cell varieties and achieves aggressive and even superior efficiency when in comparison with present state-of-the-art strategies. Lastly, CellO’s linear fashions are simply interpreted, thereby enabling exploration of cell-type-specific expression signatures throughout the ontology. To this finish, we additionally current the CellO Viewer: an internet software for exploring CellO’s fashions throughout the ontology.
Recombinant Humanp21 Recombinant Protein |
92-035 |
Recombinant phosphopantetheine adenylyltransferase (PPAT) (Recombinant) |
20-abx072018 |
Glyco Recombinant Protein A33 Recombinant Protein |
96-361 |
Glyco Recombinant Protein A33 Recombinant Protein |
96-364 |
STAG3L1 Recombinant Protein (Human) (Recombinant Tag) |
RP030283 |
Ontology-Mediated Querying with Horn Description Logics
An ontology-mediated question (OMQ) consists of a database question paired with an ontology. When evaluated on a database, an OMQ returns not solely the solutions which can be already within the database, but additionally these solutions that may be obtained by way of logical reasoning utilizing guidelines from ontology. There are a lot of open questions concerning the complexities of issues associated to OMQs. Motivated by way of ontologies in observe, new reasoning issues which have by no means been thought-about within the context of ontologies turn out to be related, since they’ll enhance the usability of ontology enriched methods.
This thesis offers with varied reasoning issues that emerge from ontology-mediated querying and it investigates the computational complexity of those issues. We deal with ontologies formulated in Horn description logics, that are a preferred alternative for ontologies in observe. Specifically, the thesis offers outcomes concerning the info complexity of OMQ analysis by fully classifying complexity and rewritability questions for OMQs primarily based on an EL ontology and a conjunctive question.
RCN3 ORF Vector (Human) (pORF) |
ORF008695 |
ABM |
1.0 ug DNA |
EUR 114 |
RCN3 cloning plasmid |
CSB-CL856914HU-10ug |
Cusabio |
10ug |
EUR 462 |
|
Description: A cloning plasmid for the RCN3 gene. |
Reticulocalbin 3 (RCN3) Antibody |
abx032616-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Reticulocalbin 3 (RCN3) Antibody |
abx032616-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Reticulocalbin 3 (RCN3) Protein |
20-abx260866 |
Abbexa |
-
EUR 4101.60
-
EUR 393.60
-
EUR 276.00
|
|
|
RCN3 protein (His tag) |
80R-2178 |
Fitzgerald |
100 ug |
EUR 386.4 |
Description: Purified recombinant Human RCN3 protein (His tag) |
RCN3 Antibody, HRP conjugated |
1-CSB-PA856914LB01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against RCN3. Recognizes RCN3 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
RCN3 Antibody, FITC conjugated |
1-CSB-PA856914LC01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against RCN3. Recognizes RCN3 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
RCN3 Antibody, Biotin conjugated |
1-CSB-PA856914LD01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against RCN3. Recognizes RCN3 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Human RCN3 shRNA Plasmid |
20-abx961415 |
Abbexa |
|
|
|
Polyclonal RCN3 Antibody (Center) |
AMM07556G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RCN3 (Center). This antibody is tested and proven to work in the following applications: |
Mouse RCN3 shRNA Plasmid |
20-abx974231 |
Abbexa |
|
|
|
RCN3 Recombinant Protein (Human) |
RP026083 |
ABM |
100 ug |
Ask for price |
RCN3 Recombinant Protein (Rat) |
RP223955 |
ABM |
100 ug |
Ask for price |
RCN3 Recombinant Protein (Mouse) |
RP167405 |
ABM |
100 ug |
Ask for price |
RCN3 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
LV646664 |
ABM |
1.0 ug DNA |
EUR 616.8 |
RCN3 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
LV646665 |
ABM |
1.0 ug DNA |
EUR 686.4 |
RCN3 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
LV646666 |
ABM |
1.0 ug DNA |
EUR 686.4 |
RCN3 Protein Vector (Human) (pPB-C-His) |
PV034777 |
ABM |
500 ng |
EUR 394.8 |
RCN3 Protein Vector (Human) (pPB-N-His) |
PV034778 |
ABM |
500 ng |
EUR 394.8 |
RCN3 Protein Vector (Human) (pPM-C-HA) |
PV034779 |
ABM |
500 ng |
EUR 394.8 |
RCN3 Protein Vector (Human) (pPM-C-His) |
PV034780 |
ABM |
500 ng |
EUR 394.8 |
RCN3 Protein Vector (Mouse) (pPB-C-His) |
PV223210 |
ABM |
500 ng |
EUR 723.6 |
RCN3 Protein Vector (Mouse) (pPB-N-His) |
PV223211 |
ABM |
500 ng |
EUR 723.6 |
RCN3 Protein Vector (Mouse) (pPM-C-HA) |
PV223212 |
ABM |
500 ng |
EUR 723.6 |
RCN3 Protein Vector (Mouse) (pPM-C-His) |
PV223213 |
ABM |
500 ng |
EUR 723.6 |
RCN3 Protein Vector (Rat) (pPB-C-His) |
PV298610 |
ABM |
500 ng |
EUR 723.6 |
RCN3 Protein Vector (Rat) (pPB-N-His) |
PV298611 |
ABM |
500 ng |
EUR 723.6 |
RCN3 Protein Vector (Rat) (pPM-C-HA) |
PV298612 |
ABM |
500 ng |
EUR 723.6 |
RCN3 Protein Vector (Rat) (pPM-C-His) |
PV298613 |
ABM |
500 ng |
EUR 723.6 |
Human Reticulocalbin 3 (RCN3) Antibody |
35620-05111 |
AssayPro |
150 ug |
EUR 313.2 |
Human Reticulocalbin 3 (RCN3)ELISA Kit |
201-12-2941 |
SunredBio |
96 tests |
EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Polyclonal RCN3 Antibody - C-terminal region |
AMM07557G |
Leading Biology |
0.05mg |
EUR 633.6 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RCN3 - C-terminal region. This antibody is tested and proven to work in the following applications: |
RCN3 sgRNA CRISPR Lentivector set (Human) |
K1804001 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Rcn3 sgRNA CRISPR Lentivector set (Rat) |
K6515801 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Rcn3 sgRNA CRISPR Lentivector set (Mouse) |
K3917901 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
RCN3 Reticulocalbin 3 Human Recombinant Protein |
PROTQ96D15 |
BosterBio |
Regular: 20ug |
EUR 380.4 |
Description: RCN3 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 333 amino acids (21-328 a.a) and having a molecular mass of 37.9kDa.;RCN3 is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
for Reticulocalbin 3 (RCN3)ELISA kit |
SEH243Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5677.8 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of for Reticulocalbin 3 (RCN3) in Tissue homogenates, cell lysates and other biological fluids. |
for Reticulocalbin 3 (RCN3)ELISA kit |
SEH243Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 572.76 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of for Reticulocalbin 3 (RCN3) in Tissue homogenates, cell lysates and other biological fluids. |
for Reticulocalbin 3 (RCN3)ELISA kit |
SEH243Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 766.8 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of for Reticulocalbin 3 (RCN3) in Tissue homogenates, cell lysates and other biological fluids. |
for Reticulocalbin 3 (RCN3)ELISA kit |
SEH243Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 3090.6 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of for Reticulocalbin 3 (RCN3) in Tissue homogenates, cell lysates and other biological fluids. |
ELISA kit for Reticulocalbin 3 (RCN3) |
4-SEH243Hu |
Cloud-Clone |
-
EUR 5738.40
-
EUR 3031.20
-
EUR 768.00
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Reticulocalbin 3 (RCN3) in samples from Tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Human Reticulocalbin 3 (RCN3) Antibody (Biotin Conjugate) |
35620-05121 |
AssayPro |
150 ug |
EUR 442.8 |
Recombinant Human Reticulocalbin-3/RCN3 (C-6His) |
CA44-10ug |
Novoprotein |
10ug |
EUR 187.2 |
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl,150mM NaCl,1mM DTT,10%Glycerol,pH7.4. |
Recombinant Human Reticulocalbin-3/RCN3 (C-6His) |
CA44-1mg |
Novoprotein |
1mg |
EUR 2739.6 |
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl,150mM NaCl,1mM DTT,10%Glycerol,pH7.4. |
Recombinant Human Reticulocalbin-3/RCN3 (C-6His) |
CA44-500ug |
Novoprotein |
500ug |
EUR 1935.6 |
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl,150mM NaCl,1mM DTT,10%Glycerol,pH7.4. |
Recombinant Human Reticulocalbin-3/RCN3 (C-6His) |
CA44-50ug |
Novoprotein |
50ug |
EUR 442.8 |
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl,150mM NaCl,1mM DTT,10%Glycerol,pH7.4. |
Bovine RCN3 (Reticulocalbin- 3) ELISA Kit (CUSTOM) |
ELI-35646b |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Human RCN3 (Reticulocalbin- 3) ELISA Kit (CUSTOM) |
ELI-41187h |
Lifescience Market |
96 Tests |
EUR 988.8 |
RCN3 sgRNA CRISPR Lentivector (Human) (Target 1) |
K1804002 |
ABM |
1.0 ug DNA |
EUR 184.8 |
RCN3 sgRNA CRISPR Lentivector (Human) (Target 2) |
K1804003 |
ABM |
1.0 ug DNA |
EUR 184.8 |
RCN3 sgRNA CRISPR Lentivector (Human) (Target 3) |
K1804004 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Mouse RCN3 (Reticulocalbin-3) ELISA Kit (CUSTOM) |
ELI-14162m |
Lifescience Market |
96 Tests |
EUR 1038 |
Rcn3 sgRNA CRISPR Lentivector (Rat) (Target 1) |
K6515802 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Rcn3 sgRNA CRISPR Lentivector (Rat) (Target 2) |
K6515803 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Rcn3 sgRNA CRISPR Lentivector (Rat) (Target 3) |
K6515804 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Rcn3 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K3917902 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Rcn3 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3917903 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Rcn3 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K3917904 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Recombinant Human RCN3 Protein, His, E.coli-1mg |
QP13290-1mg |
EnQuireBio |
1mg |
EUR 3308.4 |
Recombinant Human RCN3 Protein, His, E.coli-20ug |
QP13290-20ug |
EnQuireBio |
20ug |
EUR 241.2 |
Recombinant Human RCN3 Protein, His, E.coli-5ug |
QP13290-5ug |
EnQuireBio |
5ug |
EUR 186 |
Rcn3 3'UTR GFP Stable Cell Line |
TU267432 |
ABM |
1.0 ml |
Ask for price |
RCN3 3'UTR Luciferase Stable Cell Line |
TU019704 |
ABM |
1.0 ml |
EUR 1672.8 |
RCN3 3'UTR GFP Stable Cell Line |
TU069704 |
ABM |
1.0 ml |
EUR 1672.8 |
Rcn3 3'UTR Luciferase Stable Cell Line |
TU217432 |
ABM |
1.0 ml |
Ask for price |
Rcn3 3'UTR GFP Stable Cell Line |
TU167672 |
ABM |
1.0 ml |
Ask for price |
Rcn3 3'UTR Luciferase Stable Cell Line |
TU117672 |
ABM |
1.0 ml |
Ask for price |
Human Reticulocalbin 3 (RCN3) AssayLite Antibody (FITC Conjugate) |
35620-05141 |
AssayPro |
150 ug |
EUR 513.6 |
Human Reticulocalbin 3 (RCN3) AssayLite Antibody (RPE Conjugate) |
35620-05151 |
AssayPro |
150 ug |
EUR 513.6 |
Human Reticulocalbin 3 (RCN3) AssayLite Antibody (APC Conjugate) |
35620-05161 |
AssayPro |
150 ug |
EUR 513.6 |
Human Reticulocalbin 3 (RCN3) AssayLite Antibody (PerCP Conjugate) |
35620-05171 |
AssayPro |
150 ug |
EUR 565.2 |
RCN3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
K1804005 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
K6515805 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
K3917905 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
RCN3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
K1804006 |
ABM |
1.0 ug DNA |
EUR 200.4 |
RCN3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
K1804007 |
ABM |
1.0 ug DNA |
EUR 200.4 |
RCN3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
K1804008 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
K6515806 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
K6515807 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
K6515808 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
K3917906 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K3917907 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
K3917908 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Cas9 Nickase Lentiviral Vector |
K005 |
ABM |
10 ug |
EUR 184.8 |
Cas9 Nuclease Lentiviral Vector |
K002 |
ABM |
10 ug |
EUR 184.8 |
dCas9-KRAB Lentiviral Vector |
K203 |
ABM |
10 ug |
EUR 273.6 |
pLenti-GFP Lentiviral Control Vector |
LTV-400 |
Cell Biolabs |
100 µL |
EUR 741.6 |
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus. |
pSMPUW-MNDnLacZ Lentiviral Control Vector |
LTV-402 |
Cell Biolabs |
10 µg |
EUR 741.6 |
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus. |
Cas9 Double Mutant Lentiviral Vector |
K012 |
ABM |
10 ug |
EUR 643.2 |
pSMPUW-Puro Lentiviral Expression Vector |
VPK-212 |
Cell Biolabs |
10 µg |
EUR 748.8 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
pSMPUW-Neo Lentiviral Expression Vector |
VPK-213 |
Cell Biolabs |
10 µg |
EUR 748.8 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
pSMPUW-Hygro Lentiviral Expression Vector |
VPK-214 |
Cell Biolabs |
10 µg |
EUR 748.8 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
pSMPUW-GFP-Puro Lentiviral Control Vector |
LTV-401 |
Cell Biolabs |
10 µg |
EUR 741.6 |
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus. |
pLenti-RFP-Puro Lentiviral Control Vector |
LTV-403 |
Cell Biolabs |
100 µL |
EUR 741.6 |
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus. |
pSMPUW-GFP-LC3 Lentiviral Expression Vector |
LTV-801 |
Cell Biolabs |
10 µg |
EUR 1444.8 |
Description: Expression vector contains a fusion of GFP and LC3. A separate GFP control vector is also included. |
ESR1 Lentiviral Vector (Human) (pLenti-II) |
LV010008 |
ABM |
1.0 ug DNA |
EUR 379.2 |
pSMPUW Universal Lentiviral Expression Vector (Promoterless) |
VPK-211 |
Cell Biolabs |
10 µg |
EUR 748.8 |
Description: Clone your gene of interest and a gene-specific promoter into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293T or 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
pSMPUW-IRES-Puro Lentiviral Expression Vector |
VPK-215 |
Cell Biolabs |
10 µg |
EUR 748.8 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
pSMPUW-IRES-Neo Lentiviral Expression Vector |
VPK-216 |
Cell Biolabs |
10 µg |
EUR 748.8 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
pSMPUW-IRES-Hygro Lentiviral Expression Vector |
VPK-217 |
Cell Biolabs |
10 µg |
EUR 748.8 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
pSMPUW-IRES-Blasticidin Lentiviral Expression Vector |
VPK-219 |
Cell Biolabs |
10 µg |
EUR 748.8 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
ERAF Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810237 |
ABM |
1.0 ug DNA |
EUR 379.2 |
ERAF Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810241 |
ABM |
1.0 ug DNA |
EUR 379.2 |
ERAF Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810242 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C6orf218 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810243 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C6orf218 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810247 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C6orf218 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810248 |
ABM |
1.0 ug DNA |
EUR 379.2 |
BXDC1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810249 |
ABM |
1.0 ug DNA |
EUR 379.2 |
BXDC1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810253 |
ABM |
1.0 ug DNA |
EUR 379.2 |
BXDC1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810254 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C17orf45 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810255 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C17orf45 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810259 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C17orf45 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810260 |
ABM |
1.0 ug DNA |
EUR 379.2 |
FAM86C Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810261 |
ABM |
1.0 ug DNA |
EUR 379.2 |
FAM86C Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810265 |
ABM |
1.0 ug DNA |
EUR 379.2 |
FAM86C Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810266 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C3orf31 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810267 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C3orf31 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810271 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C3orf31 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810272 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C13orf16 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810279 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C13orf16 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810283 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C13orf16 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810284 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C21ORF55 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810285 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C21ORF55 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810289 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C21ORF55 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810290 |
ABM |
1.0 ug DNA |
EUR 379.2 |
FLJ10357 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810291 |
ABM |
1.0 ug DNA |
EUR 379.2 |
FLJ10357 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810295 |
ABM |
1.0 ug DNA |
EUR 379.2 |
FLJ10357 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810296 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C13orf3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810297 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C13orf3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810301 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C13orf3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810302 |
ABM |
1.0 ug DNA |
EUR 379.2 |
ARL17 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810303 |
ABM |
1.0 ug DNA |
EUR 379.2 |
ARL17 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810307 |
ABM |
1.0 ug DNA |
EUR 379.2 |
ARL17 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810308 |
ABM |
1.0 ug DNA |
EUR 379.2 |
HSPC047 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810309 |
ABM |
1.0 ug DNA |
EUR 379.2 |
HSPC047 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810313 |
ABM |
1.0 ug DNA |
EUR 379.2 |
HSPC047 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810314 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C9orf68 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810315 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C9orf68 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810319 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C9orf68 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810320 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C18orf22 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810321 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C18orf22 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810325 |
ABM |
1.0 ug DNA |
EUR 379.2 |
C18orf22 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810326 |
ABM |
1.0 ug DNA |
EUR 379.2 |
KIAA0774 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810327 |
ABM |
1.0 ug DNA |
EUR 379.2 |
KIAA0774 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810331 |
ABM |
1.0 ug DNA |
EUR 379.2 |
KIAA0774 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810332 |
ABM |
1.0 ug DNA |
EUR 379.2 |
BXDC5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810333 |
ABM |
1.0 ug DNA |
EUR 379.2 |
BXDC5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810337 |
ABM |
1.0 ug DNA |
EUR 379.2 |
BXDC5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810338 |
ABM |
1.0 ug DNA |
EUR 379.2 |
IL8RA Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810339 |
ABM |
1.0 ug DNA |
EUR 379.2 |
IL8RA Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810343 |
ABM |
1.0 ug DNA |
EUR 379.2 |
IL8RA Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810344 |
ABM |
1.0 ug DNA |
EUR 379.2 |
RBM9 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810345 |
ABM |
1.0 ug DNA |
EUR 379.2 |
RBM9 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810349 |
ABM |
1.0 ug DNA |
EUR 379.2 |
RBM9 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810350 |
ABM |
1.0 ug DNA |
EUR 379.2 |
FAM62B Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810351 |
ABM |
1.0 ug DNA |
EUR 379.2 |
FAM62B Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810355 |
ABM |
1.0 ug DNA |
EUR 379.2 |
FAM62B Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810356 |
ABM |
1.0 ug DNA |
EUR 379.2 |
BC013798 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810357 |
ABM |
1.0 ug DNA |
EUR 379.2 |
BC013798 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV810361 |
ABM |
1.0 ug DNA |
EUR 379.2 |
BC013798 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV810362 |
ABM |
1.0 ug DNA |
EUR 379.2 |
RTCD1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV810363 |
ABM |
1.0 ug DNA |
EUR 379.2 |
Moreover, the query-by-example downside, and the expressibility and verification downside in ontology-based knowledge entry are launched and investigated.